Retroviral vectors related to the myeloproliferative sarcoma virus allow efficient expression in hematopoietic stem and precursor cell lines, but retroviral infection is reduced in more primitive cells.
AffiliationHeinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Universität Hamburg, Federal Republic of Germany.
MetadataShow full item record
AbstractRetroviral vectors are considered to be the most suited vehicles for somatic gene therapy with hematopoietic stem cells as targets. Retrovirus-mediated gene transfer into differentiation-restricted hematopoietic precursor (FDC-P1, FDC-P2) and multipotent progenitor (stem) cell lines (FDC-Pmix) is inefficient. Two cellular restrictions are involved. One is specific for stem but not precursor cells and is at the level of transcription. Due to a unique property of the transcriptional control region of the myeloproliferative sarcoma virus (MPSV), vectors derived from MPSV are not affected by this block. The second restriction occurs before proviral DNA synthesis and integration. This inhibition of effective viral infection depends on the state of differentiation, being more pronounced in multipotent clonogenic blast cells. This block to retroviral infection affects all retroviral vectors tested.
CitationRetroviral vectors related to the myeloproliferative sarcoma virus allow efficient expression in hematopoietic stem and precursor cell lines, but retroviral infection is reduced in more primitive cells. 1991, 2 (1):61-70 Hum. Gene Ther.
JournalHuman Gene Therapy
- The myeloproliferative sarcoma virus retains transforming functions after introduction of a dominant selectable marker gene.
- Authors: Ostertag W, Seliger B, Kollek R, Stocking C, Bergholz U, Smadja-Joffe F
- Issue date: 1986 Jul
- Targeted in vivo infection with a retroviral vector carrying the interleukin-3 (multi-CSF) gene leads to immortalization and leukemic transformation of primitive hematopoietic progenitor cells.
- Authors: Just U, Katsuno M, Stocking C, Spooncer E, Dexter M
- Issue date: 1993
- Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesis.
- Authors: Baum C, Eckert HG, Stocking C, Ostertag W
- Issue date: 1996 Feb
- Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
- Authors: Baum C, Hegewisch-Becker S, Eckert HG, Stocking C, Ostertag W
- Issue date: 1995 Dec
- Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model.
- Authors: Hanania EG, Deisseroth AB
- Issue date: 1994 Mar